Please select the option that best describes you:

Topics: Breast Cancer • Medical Oncology • HR+ • Breast Cancer, Non-metastatic

Would you offer adjuvant ribociclib to a postmenopausal female with ER+ luminal A, node+ breast cancer pT1cN1a grade 2 that didn't require chemotherapy per OncoType, but met NATALEE inclusion criteria?